Safety of Baricitinib in Japanese Patients with Rheumatoid Arthritis (RA): The 2020 Interim Report from All-case Post Marketing Surveillance in Clinical Practice

被引：0
|
作者：
Fujii, Takao [1 ]
Atsumi, Tatsuya [2 ]
Okamoto, Nami [3 ]
Takahashi, Nobunori [4 ]
Tamura, Naoto [5 ]
Nakajima, Atsuo [6 ]
Nakajima, Ayako [7 ]
Matsuno, Hiroaki [8 ]
Tsujimoto, Naoto [9 ]
Nishikawa, Atsushi [9 ]
Ishii, Taeko [9 ]
Takeuchi, Tsutomu [10 ]
Kuwana, Masataka [11 ]
Takagi, Michiaki [12 ]
机构：
[1] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan
[2] Hokkaido Univ, Sapporo, Hokkaido, Japan
[3] Osaka Med Coll, Takatsuki, Osaka, Japan
[4] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[5] Juntendo Univ, Fac Med, Dept Internal Med & Rheumatol, Tokyo, Japan
[6] Ueno Touseki Clin, Fukuoka, Japan
[7] Mie Univ Hosp, Ctr Rheumat Dis, Tsu, Mie, Japan
[8] Matsuno Clin Rheumat Dis, Toyama, Japan
[9] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[10] Keio Univ, Div Rheumatol, Tokyo, Japan
[11] Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan
[12] Yamagata Univ, Fac Med, Dept Orthopaed Surg, Yamagata, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1676
引用
收藏
页码：3489 / 3490
页数：2
相关论文
共 50 条
  • [31] Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice - A Post-Marketing Surveillance -
    Yamada, Norikazu
    Mo, Makoto
    Ohsawa, Ako
    Sato, Motoki
    Umeyama, Michiaki
    Shima, Daisuke
    Nakamura, Mashio
    CIRCULATION JOURNAL, 2021, 85 (12) : 2201 - +
  • [32] Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
    Nobunori Takahashi
    Shuji Asai
    Tomonori Kobayakawa
    Atsushi Kaneko
    Tatsuo Watanabe
    Takefumi Kato
    Tsuyoshi Nishiume
    Hisato Ishikawa
    Yutaka Yoshioka
    Yasuhide Kanayama
    Tsuyoshi Watanabe
    Yuji Hirano
    Masahiro Hanabayashi
    Yuichiro Yabe
    Yutaka Yokota
    Mochihito Suzuki
    Yasumori Sobue
    Kenya Terabe
    Naoki Ishiguro
    Toshihisa Kojima
    Scientific Reports, 10
  • [33] Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
    Kuwana, Masataka
    Sugiyama, Naonobu
    Momohara, Shigeki
    Atsumi, Tatsuya
    Takei, Syuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Tanigawa, Miki
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    Mimori, Tsuneyo
    Takagi, Michiaki
    MODERN RHEUMATOLOGY, 2024, 34 (02) : 272 - 286
  • [34] All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis
    Ogura, Takashi
    Azuma, Arata
    Inoue, Yoshikazu
    Taniguchi, Hiroyuki
    Chida, Kingo
    Bando, Masashi
    Niimi, Yuka
    Kakutani, Shinichi
    Suga, Moritaka
    Sugiyama, Yukihiko
    Kudoh, Shoji
    Nukiwa, Toshihiro
    RESPIRATORY INVESTIGATION, 2015, 53 (05) : 232 - 241
  • [35] Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study
    Kuwana, Masataka
    Sugiyama, Naonobu
    Momohara, Shigeki
    Atsumi, Tatsuya
    Takei, Syuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Okamoto, Nami
    Takahashi, Nobunori
    Nakajima, Atsuo
    Nakajima, Ayako
    Tanigawa, Miki
    Endo, Yutaka
    Hirano, Toshitaka
    Hoshi, Masato
    Mimori, Tsuneyo
    Takagi, Michiaki
    Tanaka, Sakae
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2025,
  • [36] Safety and effectiveness of denosumab in Japanese patients with rheumatoid arthritis: A 2-year post-marketing surveillance study
    Tanaka, Yoshiya
    Mizutani, Hideki
    Fujii, Kunimitsu
    Okubo, Naoki
    MODERN RHEUMATOLOGY, 2023, 34 (05) : 927 - 935
  • [37] Impact of gender on outcome of Japanese patients with rheumatoid arthritis: The post marketing surveillance trial.
    Dabbous, O.
    Rahman, M. I.
    Gilmer, K.
    Yano, T.
    Nogami, Y.
    Arjunji, R.
    Thompson, H.
    Tang, B.
    Takeuchi, T.
    Koike, T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S55 - S55
  • [38] Safety of crizotinib in 892 Japanese ALK-positive advanced NSCLC patients: Interim report of post-marketing surveillance
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    Ohe, Yuichiro
    Ueno, Naomi
    Banno, Shigeo
    Endo, Yutaka
    Ohki, Emiko
    Gemma, Akihiko
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 37
  • [39] Safety and Efficacy of Fingolimod in Japanese Patients with Multiple Sclerosis: Interim Analysis Results from Post-marketing Surveillance
    Kira, J.
    Fujihara, K.
    Ueda, K.
    Tajima, T.
    Ueno, M.
    Saida, T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 928 - 928
  • [40] Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study
    Kameda, Hideto
    Nishida, Keiichiro
    Nanki, Toshihiro
    Watanabe, Akira
    Oshima, Yukiya
    Momohara, Shigeki
    MODERN RHEUMATOLOGY, 2023, 33 (03) : 460 - 471
12345